Murali Kesavan
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
Journal: British journal of haematology
Published: September 05, 2024
Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib.
Journal: Haematologica
Published: June 22, 2022
Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.
Journal: British journal of haematology
Published: March 28, 2022
Cellular Therapy in High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter Syndrome.
Cellular Therapy in High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter Syndrome.
Journal: Frontiers in oncology
Published: March 02, 2022
Myeloid Toxicity of Radionuclide Cancer Therapy.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: December 06, 2021
Long-term efficacy and safety of chemotherapy-free first-line iodine-131-rituximab radioimmunotherapy of follicular lymphoma.
Journal: British journal of haematology
Published: August 09, 2021
Long-term hematologic toxicity of 177Lu-octreotate-capecitabine-temozolomide therapy of GEPNET.
Journal: Endocrine-related cancer
Published: April 26, 2021
Efficacy and Haematologic Toxicity of Palliative Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen in Heavily Pre-Treated Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: March 02, 2021
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.
Journal: Current hematologic malignancy reports
Published: June 30, 2019
Last Updated: 09/26/2026